Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)
===========================================================================================================================================================================

* Michael B Atkins
* Opeyemi A Jegede
* Naomi B Haas
* David F Mcdermott
* Mehmet A Bilen
* Mark Stein
* Jeffrey Sosman
* Robert Alter
* Elizabeth R Plimack
* Moshe C Ornstein
* Michael Hurwitz
* David J Peace
* David Einstein
* Paul J Catalano
* Hans Hammers
* Meredith M Regan